A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention
NCT ID: NCT04804033
Last Updated: 2025-03-27
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2/PHASE3
1753 participants
INTERVENTIONAL
2021-03-26
2024-03-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Randomized Trial in Adult Participants With Acute Migraines
NCT04571060
Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications
NCT06401642
Long-term Safety Study of BHV-3500 (Zavegepant*) for the Acute Treatment of Migraine
NCT04408794
Acute Treatment Trial in Adult Subjects With Migraines
NCT03872453
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
NCT06995729
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SEQUENTIAL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BHV-3500 200mg
Zavegepant 200mg oral soft gel capsule.
BHV-3500 (zavegepant)
BHV-3500 (zavegepant) softgel capsule.
Placebo 200mg
Matching placebo 200mg oral soft gel capsule.
Placebo
Matching placebo softgel capsule.
BHV-3500 100mg
Zavegepant 100mg oral soft gel capsule.
BHV-3500 (zavegepant)
BHV-3500 (zavegepant) softgel capsule.
Placebo 100mg
Matching placebo 100mg oral soft gel capsule.
Placebo
Matching placebo softgel capsule.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BHV-3500 (zavegepant)
BHV-3500 (zavegepant) softgel capsule.
Placebo
Matching placebo softgel capsule.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Headache Disorders, 3rd Edition, including the following:
1. Age of onset of migraines prior to 50 years of age
2. Migraine attacks, on average, lasting 4 - 72 hours if untreated
3. Per subject report, at least 15 headache days per month, at lest 8 migraine days per month, and at least 1 headache-free day per month within the last 3 months prior to the Screening Visit
4. Eight or more migraine days during the Observation Period
5. 15 or more headache days during the Observation Period
6. One or more non-headache days during the Observation Period
7. Ability to distinguish migraine attacks from tension/cluster headaches
8. Subjects on prophylactic migraine medication are permitted to remain on 1 medication with possible migraine-prophylactic effects if the dose has been stable for at least 3 months prior to the Screening Visit, and the dose is not expected to change during the course of the study.
Exclusion Criteria
2. Subject history with current evidence of uncontrolled, unstable or recently diagnosed cardiovascular disease, such as ischemic heart disease, coronary artery vasospasm, and cerebral ischemia. Subjects with Myocardial Infarction (MI), Acute Coronary Syndrome (ACS), Percutaneous Coronary Intervention (PCI), cardiac surgery, stroke or transient ischemic attack (TIA) during the 6 months prior to screening
3. Uncontrolled hypertension (high blood pressure), or uncontrolled diabetes (however subjects can be included who have stable hypertension and/or diabetes for at least 3 months prior to screening).
4. Subjects with major depressive episode or anxiety disorder which require more than 1 daily medication for each disorder or subjects with a major depressive episode within the last 12 months. Medications to treat major depressive disorder or an anxiety disorder must have been at a stable dose for at least 3 months prior to the Screening Visit.
5. Subjects with active chronic pain syndromes, other pain syndromes (including trigeminal neuralgia), psychiatric conditions, dementia, or significant neurological disorders (other than migraine) that, in the Investigator's opinion interfere with study assessments of safety or efficacy.
6. Subject has a history of gastric, or small intestinal surgery (including Gastric Bypass, Gastric Banding, Gastric Sleeve, Gastric Balloon, etc.), or has disease or condition (e.g. chronic pancreatitis, ulcerative colitis, etc.) that causes malabsorption.
7. Body mass index \> 33 kg/m2
8. History of gallstones or cholecystectomy.
9. The subject has a history or current evidence of any unstable medical conditions (e.g., history of congenital heart disease or arrhythmia, known or suspected infection, hepatitis B or C, or cancer) that, in the investigator's opinion, would expose them to undue risk of a significant adverse event (AE) or interfere with assessments of safety or efficacy during the course of the trial
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xenoscience, Inc
Phoenix, Arizona, United States
Tucson Neuroscience Research
Tucson, Arizona, United States
Hope Clinical Research
Canoga Park, California, United States
Axiom Research, Llc
Colton, California, United States
Wr-Pri, Llc
Encino, California, United States
eStudySite
La Mesa, California, United States
Synergy San Diego
Lemon Grove, California, United States
Collaborative Neuroscience Research, LLC.
Long Beach, California, United States
Clinical Research Institute
Los Angeles, California, United States
Wr-Pri, Llc
Newport Beach, California, United States
Artemis Institute for Clinical Research
San Diego, California, United States
California Neuroscience Research Medical Group, inc.
Sherman Oaks, California, United States
CMR of Greater New Haven, LLC
Hamden, Connecticut, United States
Ki Health Partners, LLc, dba New England Institute for Clinical Research
Stamford, Connecticut, United States
Chase Medical Research, LLC
Waterbury, Connecticut, United States
Neurology Offices of South Florida
Boca Raton, Florida, United States
Accel Research Sites Network - Edgewater Clinical Research Unit
Edgewater, Florida, United States
Complete Health Research
Edgewater, Florida, United States
Sarkis Clinical Trials
Gainesville, Florida, United States
Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
Multi-Specialty Research Associates, Inc.
Lake City, Florida, United States
AppleMed Research Group, LLC
Miami, Florida, United States
AppleMed Research Group, LLC
Miami, Florida, United States
Brainstorm Research
Miami, Florida, United States
The Neurology Research Group
Miami, Florida, United States
Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
Complete Health Research
Ormond Beach, Florida, United States
Ideal Clinical Research
Pembroke Pines, Florida, United States
Clinical Research Center of Florida
Pompano Beach, Florida, United States
Clin-Med Research & Development LLC
South Miami, Florida, United States
Accel Research Sites Network - St. Petersburg Clinical Research Unit
St. Petersburg, Florida, United States
ForCare Clinical Research
Tampa, Florida, United States
JSV Clinical Research Study Inc
Tampa, Florida, United States
CenExel iResearch, LLC
Decatur, Georgia, United States
iResearch Atlanta LLC
Decatur, Georgia, United States
Cedar Crosse Research Center
Chicago, Illinois, United States
Clinical Investigation Specialists, Inc.
Gurnee, Illinois, United States
Clinical Investigation Specialists, Inc
Gurnee, Illinois, United States
MediSphere Medical Research Center, LLC.
Evansville, Indiana, United States
MediSphere Medical Research Center, LLC
Evansville, Indiana, United States
Meridian Clinical Research, LLC
Sioux City, Iowa, United States
Alliance for Multispecialty Reseach, LLC
El Dorado, Kansas, United States
Alliance for Multispecialty Research, LLC
Newton, Kansas, United States
Collevtive Medical Research
Overland Park, Kansas, United States
Kansas Institute of Research
Overland Park, Kansas, United States
The Research Group of Lexington, Llc.
Lexington, Kentucky, United States
The Research Group of Lexington, Llc
Lexington, Kentucky, United States
L-MARC Research Center
Louisville, Kentucky, United States
Crescent City Headache and Neurology Center
Chalmette, Louisiana, United States
Alliance for Multispecialty Research, LLC.
New Orleans, Louisiana, United States
DelRicht Research
New Orleans, Louisiana, United States
Boston Clinical Trials
Boston, Massachusetts, United States
Neurology Center of New England P.C.
Foxborough, Massachusetts, United States
Community Clinical Research Network Inc
Marlborough, Massachusetts, United States
MedVadis Research Corporation
Waltham, Massachusetts, United States
Michigan Head Pain & Neurological Institute
Ann Arbor, Michigan, United States
Romedica LLC
Rochester, Michigan, United States
StudyMetrix Research
City of Saint Peters, Missouri, United States
Alliance for Multispecialty Reseach, LLC
Kansas City, Missouri, United States
Clinvest Research, LLC
Springfield, Missouri, United States
Clinvest Research, LLC
Springfield, Missouri, United States
Meridian Clinical Research, LLC
Norfolk, Nebraska, United States
Excel Clinical research
Las Vegas, Nevada, United States
Wr-Crcn, Llc
Las Vegas, Nevada, United States
Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico, United States
Dent Neurosciences Research Center, Inc.
Amherst, New York, United States
Central New York Clinical Research
Manlius, New York, United States
New York Neurology Associates
New York, New York, United States
Fieve Clinical Research, Inc
New York, New York, United States
North Suffolk Neurology, PC
Port Jefferson Station, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Upstate Clinical Research Associates, LLC
Williamsville, New York, United States
Headache Wellness Center
Greensboro, North Carolina, United States
Accellacare
Raleigh, North Carolina, United States
M3 Wake Research, Inc.
Raleigh, North Carolina, United States
Carolina Research Center, Inc.
Shelby, North Carolina, United States
Accellacare
Wilmington, North Carolina, United States
CTI Clinical Research Center
Cincinnati, Ohio, United States
WellNow Urgent Care and Research
Cincinnati, Ohio, United States
Wellnow Urgent Care
Cincinnati, Ohio, United States
Hometown Urgent Care and Research
Columbus, Ohio, United States
Wellnow Urgent Care and Research
Columbus, Ohio, United States
Hometown Urgent Care and Research
Dayton, Ohio, United States
WellNow Urgent Care and Research
Dayton, Ohio, United States
Neuro-Behavioral Clinical Research, Inc.
North Canton, Ohio, United States
WellNow Urgent Care and Research
Troy, Ohio, United States
Hightower Clinical
Oklahoma City, Oklahoma, United States
Hightower Clinical
Oklahoma City, Oklahoma, United States
Summit Headlands LLC, dba Summit Research
Portland, Oregon, United States
Clinical Research Philadelphia, LLC
Philadelphia, Pennsylvania, United States
Preferred Primary Care Physicians, Inc.
Pittsburgh, Pennsylvania, United States
Preferred Primary Care Physicians
Uniontown, Pennsylvania, United States
Reading Hospital Clinical Trials Office
West Reading, Pennsylvania, United States
Tower Health Medical Group - Neurology
West Reading, Pennsylvania, United States
Coastal Carolina Research Center
North Charleston, South Carolina, United States
Accellacare (Administrative Only)
Bristol, Tennessee, United States
Internal Medicine and Pediatric Associates of Bristol, PC
Bristol, Tennessee, United States
WR-ClinSearch, LLC
Chattanooga, Tennessee, United States
KCA Neurology, PLLC
Franklin, Tennessee, United States
Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, United States
FutureSearch Trials of Neurology
Austin, Texas, United States
FutureSearch Trials of Dallas, LP
Dallas, Texas, United States
North Texas Institute of Neurology and Headache - NextStage Clinical Research
Frisco, Texas, United States
North Texas Institute of Neurology and Headache
Frisco, Texas, United States
Texas Center for Drug Development, Inc.
Houston, Texas, United States
Red Star Research. LLC
Lake Jackson, Texas, United States
FMC Science
Lampasas, Texas, United States
Radiance Clinical Research
Lampasas, Texas, United States
DM Clinical Research
Tomball, Texas, United States
Wasatch Clinical Research , LLC(Administrative Location)
Salt Lake City, Utah, United States
Charlottesville Medical Research Center, LLC
Charlottesville, Virginia, United States
Health Research of Hampton Roads, Inc.
Newport News, Virginia, United States
Meridian Clinical Research, LLC
Norfolk, Virginia, United States
Northwest Clinical Research Center
Bellevue, Washington, United States
Seattle Clinical Research Center
Seattle, Washington, United States
Seattle Women's: Health, Research, Gynecology
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C5301006
Identifier Type: OTHER
Identifier Source: secondary_id
BHV3500-302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.